Ripretinib intrapatient dose escalation after disease progression provides clinically meaningful outcomes in advanced gastrointestinal stromal tumour

Suzanne George, Ping Chi, Michael C. Heinrich, Margaret von Mehren, Robin L. Jones, Kristen Ganjoo, Jonathan Trent, Hans Gelderblom, Albiruni A. Razak, Michael S. Gordon, Neeta Somaiah, Julia Jennings, Julie Meade, Kelvin Shi, Ying Su, Rodrigo Ruiz-Soto, Filip Janku

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Ripretinib intrapatient dose escalation after disease progression provides clinically meaningful outcomes in advanced gastrointestinal stromal tumour'. Together they form a unique fingerprint.

Medicine & Life Sciences